MIG USA, a North Carolina Company, to Bring Needed Relief Through the Provision of Coronavirus Test Kits

Editorial & Advertiser Disclosure Global Banking And Finance Review is an independent publisher which offers News, information, Analysis, Opinion, Press Releases, Reviews, Research reports covering various economies, industries, products, services and companies. The content available on globalbankingandfinance.com is sourced by a mixture of different methods which is not limited to content produced and supplied by various staff writers, journalists, freelancers, individuals, organizations, companies, PR agencies Sponsored Posts etc. The information available on this website is purely for educational and informational purposes only. We cannot guarantee the accuracy or applicability of any of the information provided at globalbankingandfinance.com with respect to your individual or personal circumstances. Please seek professional advice from a qualified professional before making any financial decisions. Globalbankingandfinance.com also links to various third party websites and we cannot guarantee the accuracy or applicability of the information provided by third party websites. Links from various articles on our site to third party websites are a mixture of non-sponsored links and sponsored links. Only a very small fraction of the links which point to external websites are affiliate links. Some of the links which you may click on our website may link to various products and services from our partners who may compensate us if you buy a service or product or fill a form or install an app. This will not incur additional cost to you. A very few articles on our website are sponsored posts or paid advertorials. These are marked as sponsored posts at the bottom of each post. For avoidance of any doubts and to make it easier for you to differentiate sponsored or non-sponsored articles or links, you may consider all articles on our site or all links to external websites as sponsored . Please note that some of the services or products which we talk about carry a high level of risk and may not be suitable for everyone. These may be complex services or products and we request the readers to consider this purely from an educational standpoint. The information provided on this website is general in nature. Global Banking & Finance Review expressly disclaims any liability without any limitation which may arise directly or indirectly from the use of such information.

MIG USA, LLC (Mjalli Investment Group), a High Point, North Carolina company having focus in the biotechnology, pharmaceutical, and clinical research sectors, along with its corporate partner, have acquired the exclusive rights to manufacture and distribute a rapid-result coronavirus test kit, the VITAK-19, for immediate availability to local, national and worldwide medical communities. The company now has a substantial quantity of test kits to supply the emergency need. The company will provide 500,000 kits within 24-48 hours and 100,000 per day thereafter. This test simply requires a fingertip blood sample and results are generated in approximately 8 minutes. The test can also be self-administered, similar to a diabetes home-screening, allowing individuals or healthcare providers to follow the instructions provided within the kit.

Dr. Adnan M. Mjalli, the Executive Chairman says: We at MIG USA are very excited to have the VITAK-19 which will have a significant impact on the war against the coronavirus to detect the virus quickly and efficiently and we are working very hard to make the kits accessible to all medical communities throughout the U.S. This IgM/IgG kit (VITAK-19) is a rapid point-of-care test for COVID antibodies.

MIG USA, LLC will ramp up a manufacturing site in High Point, North Carolina for production of the kits for additional supply. Further, the company has engaged a strong research and development team to develop a wide range of anti-virus solutions to ensure immediate response and prophylactic measures to combat diseases similar to the coronavirus.

Stacey Kraftchick [email protected]; 843.670.074

Noor Al Saamri [email protected]; 336.259.5858

Dr. Adnan M. Mjalli [email protected]; 336.847.6025

www.migusa.com